売上総利益、当期純利益、減損損失 - 医薬品
- 【期間】
| 年度 | 売上総利益 | 当期純利益 | 減損損失 - 医薬品 |
|---|
| 2008/03 | 387億 | | 23.3億 | | - | |
| 2009/03 | 408億 | +5.5% | 20.6億 | -11.4% | - | |
| 2009/12 | 312億 | -23.5% | 42.1億 | +104% | - | |
| 2010/03 | 405億 | +29.6% | 43.7億 | +3.9% | - | |
| 2010/06 | 111億 | -72.6% | 12.5億 | -71.5% | - | |
| 2010/09 | 213億 | +92% | 14.5億 | +16.3% | - | |
| 2010/12 | 323億 | +51.5% | 32.5億 | +124.6% | - | |
| 2011/03 | 419億 | +29.9% | 40億 | +23% | - | |
| 2011/06 | 100億 | -76.1% | 13.4億 | -66.6% | - | |
| 2011/09 | 206億 | +105.2% | 24.7億 | +84.8% | - | |
| 2011/12 | 318億 | +54.5% | 39.6億 | +60.1% | - | |
| 2012/03 | 417億 | +31.2% | 47.7億 | +20.6% | - | |
| 2012/06 | 99億 | -76.3% | 14.4億 | -69.7% | - | |
| 2012/09 | 201億 | +103.5% | 18.2億 | +25.9% | - | |
| 2012/12 | 316億 | +56.8% | 43.7億 | +140.5% | - | |
| 2013/03 | 413億 | +30.9% | 50.2億 | +14.9% | - | |
| 2013/06 | 110億 | -73.4% | 24.3億 | -51.6% | - | |
| 2013/09 | 216億 | +96.4% | 37.8億 | +55.7% | - | |
| 2013/12 | 368億 | +70.5% | 87.2億 | +130.6% | - | |
| 2014/03 | 472億 | +28.3% | 90.9億 | +4.3% | - | |
| 2014/06 | 107億 | -77.4% | 22.7億 | -75% | - | |
| 2014/09 | 230億 | +114.9% | 45億 | +98.5% | - | |
| 2014/12 | 349億 | +52% | 74.5億 | +65.4% | - | |
| 2015/03 | 460億 | +31.9% | 71.7億 | -3.8% | - | |
| 2015/06 | 116億 | -74.9% | 22.7億 | -68.4% | - | |
| 2015/09 | 228億 | +97.5% | 39.5億 | +74.3% | - | |
| 2015/12 | 368億 | +61.1% | 88.1億 | +123.1% | - | |
| 2016/03 | 477億 | +29.8% | 78.8億 | -10.5% | - | |
| 2016/06 | 123億 | -74.2% | 28.3億 | -64% | - | |
| 2016/09 | 232億 | +88.5% | 36.8億 | +29.8% | - | |
| 2016/12 | 359億 | +54.5% | 70.4億 | +91.4% | - | |
| 2017/03 | 466億 | +29.8% | 74億 | +5.1% | 47百万 | |
| 2017/06 | 126億 | -73% | 21億 | -71.6% | - | |
| 2017/09 | 243億 | +92.6% | 42.8億 | +103.7% | - | |
| 2017/12 | 374億 | +54.4% | 80.5億 | +88.1% | - | |
| 2018/03 | 481億 | +28.5% | 86.3億 | +7.2% | - | |
| 2018/06 | 115億 | -76.2% | 27.4億 | -68.2% | - | |
| 2018/09 | 222億 | +93.4% | 33.4億 | +21.7% | - | |
| 2018/12 | 351億 | +58.4% | 42.7億 | +28% | - | |
| 2019/03 | 456億 | +29.9% | 50.6億 | +18.6% | 49百万 | +4.3% |
| 2019/06 | 100億 | -78% | 20.1億 | -60.3% | - | |
| 2019/09 | 187億 | +86.2% | 21.5億 | +6.9% | - | |
| 2019/12 | 278億 | +48.7% | 35.4億 | +64.7% | - | |
| 2020/03 | 349億 | +25.6% | 22.1億 | -37.7% | - | |
| 2020/06 | 82.6億 | -76.3% | 17.3億 | -21.8% | - | |
| 2020/09 | 161億 | +94.9% | 44億 | +154.8% | - | |
| 2020/12 | 255億 | +58.5% | 64.4億 | +46.5% | - | |
| 2021/03 | 327億 | +28.2% | 46.1億 | -28.4% | - | |
| 2021/06 | 78.7億 | -76% | 36.4億 | -20.9% | - | |
| 2021/09 | 155億 | +96.6% | 56.7億 | +55.5% | - | |
| 2021/12 | 241億 | +55.9% | 68.2億 | +20.3% | - | |
| 2022/03 | 312億 | +29.6% | 123億 | +79.7% | - | |
| 2022/06 | 81.5億 | -73.9% | 16.4億 | -86.7% | - | |
| 2022/09 | 162億 | +98.6% | 33.3億 | +103.4% | - | |
| 2022/12 | 254億 | +56.9% | 66.7億 | +100.5% | - | |
| 2023/03 | 324億 | +27.5% | 99.1億 | +48.6% | - | |
| 2023/06 | 95.8億 | -70.4% | 32.7億 | -67.1% | - | |
| 2023/09 | 183億 | +91% | 56.8億 | +73.9% | - | |
| 2023/12 | 286億 | +56.1% | 83.4億 | +46.8% | - | |
| 2024/03 | 373億 | +30.7% | 103億 | +23.6% | - | |
| 2024/06 | 109億 | -70.9% | 41.1億 | -60.2% | - | |
